Xu FangPing, Liu ZhiHua, Yan JinHai, Yan Lixu, Qiu ZhenBin, Ge Yan, Lv ShanShan, Zhong WenZhao
Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080, Guangzhou, Guangdong, China.
Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080, Guangzhou, Guangdong, China.
Eur J Surg Oncol. 2025 Aug;51(8):108747. doi: 10.1016/j.ejso.2024.108747. Epub 2024 Oct 8.
Intraoperative assessment of tumor spread through air spaces (STAS) in early-stage lung adenocarcinomas (ADC) has been proposed to stratify patients for surgical management. However, data on the accuracy and reproducibility of detecting STAS on frozen sections (FS) and the prognostic value of STAS on FS remain limited and contradictory.
We conducted a retrospective study on the feasibility of intraoperative assessment of STAS by comparing the STAS patterns identified on FS and permanent sections from 524 patients diagnosed with pathologic stage 1 lung ADC. We also evaluated the association between STAS with patients' clinicopathological characteristics and their postoperative survival outcomes.
STAS was identified in 117 out of 524 patients (22.3 %) on permanent sections. Patients with STAS identified on permanent sections experienced shorter progression-free survival (PFS; P = 0.042) and overall survival (OS; P = 0.005) compared to those without. STAS was identified in 87 out of 509 patients on FS. Patients with STAS detected on FS also had shorter PFS (P = 0.010) and OS (P < 0.001) than those without. Compared to permanent sections, STAS detection on FS yielded 66.7 % (74/111) sensitivity, 96.7 % (385/398) specificity, 85.1 % (74/87) positive predictive value, 91.2 % (385/422) negative predictive value, and 90.2 % (459/509) overall agreement. The kappa coefficient was 0.688 (P < 0.001).
Our results from a large series of Chinese patients with stage 1 lung ADC indicated that STAS was associated with poorer survival outcomes on both FS and permanent sections. FS is a highly specific method for assessing STAS in stage 1 lung ADC, but caution is warranted regarding false-positive results.
对于早期肺腺癌(ADC),术中评估肿瘤通过气腔的播散(STAS)已被提议用于对患者进行手术管理分层。然而,关于在冰冻切片(FS)上检测STAS的准确性和可重复性以及FS上STAS的预后价值的数据仍然有限且相互矛盾。
我们进行了一项回顾性研究,通过比较524例病理分期为1期肺ADC患者的FS和永久切片上识别出的STAS模式,评估术中评估STAS的可行性。我们还评估了STAS与患者临床病理特征及其术后生存结果之间的关联。
在524例患者中的117例(22.3%)永久切片上识别出STAS。与未识别出STAS的患者相比,在永久切片上识别出STAS的患者无进展生存期(PFS;P = 0.042)和总生存期(OS;P = 0.005)更短。在509例患者中的87例FS上识别出STAS。在FS上检测到STAS的患者的PFS(P = 0.010)和OS(P < 0.001)也比未检测到的患者短。与永久切片相比,FS上STAS检测的敏感性为66.7%(74/111),特异性为96.7%(385/398),阳性预测值为85.1%(74/87),阴性预测值为91.2%(385/422),总体一致性为90.2%(459/509)。kappa系数为0.688(P < 0.001)。
我们对大量中国1期肺ADC患者的研究结果表明,FS和永久切片上的STAS均与较差的生存结果相关。FS是评估1期肺ADC中STAS的一种高度特异性方法,但对于假阳性结果需谨慎。